NABP Newsroom

Bills to Safeguard Medications Through National Tracking System Under Consideration in Congress

Wed, 12 Jun 2013 16:15:00 -0500

A bill aimed to ensure the security of pharmaceuticals in the drug supply chain has passed the United States House of Representatives.

FDA Observes 20 Years of Supporting Medication Safety Through MedWatch Program

Wed, 12 Jun 2013 15:40:00 -0500

For 20 years, FDA’s MedWatch program has supported medication safety efforts by providing a means for health care providers and consumers to report safety information regarding FDA-regulated products.

FDA Announces Opportunity for Expansion of ‘Script Your Future’ Medication Adherence Program

Wed, 12 Jun 2013 15:30:00 -0500

FDA has announced the availability of grant funds intended to support the National Consumers League (NCL) in expanding efforts to educate the public about medication adherence.

July DEA Conference on Preventing Drug Diversion Open to Pharmacy Personnel in Oregon

Wed, 12 Jun 2013 15:00:00 -0500

Drug Enforcement Administration (DEA) is offering two regional one-day Pharmacy Diversion Awareness Conferences (PDACs) in Portland, OR.

Legal Briefs | Battery Conviction Recharged

Wed, 12 Jun 2013 00:00:00 -0500

Many legislatures have enacted so called “social legislation” intended to empower regulatory boards to impose administrative sanctions against licensees for certain delineated activities.

2012-2013 Report of the Committee on Law Enforcement/Legislation Released

Fri, 07 Jun 2013 00:00:00 -0500

The Committee on Law Enforcement/Legislation met January 22-23, 2013.

Tennessee Pharmacy Voluntarily Recalls Sterile Compounded Products, FDA Works With State Regulators in Ongoing Investigation

Wed, 05 Jun 2013 17:30:00 -0500

Food and Drug Administration (FDA) has issued an alert warning against the use of sterile products compounded and dispensed by Main Street Family Pharmacy, LLC, of Newbern, TN.

FDA Allows Import of Injectable Nutritional Drugs Due to Product Shortage

Wed, 05 Jun 2013 17:25:00 -0500

FDA will allow the import of injectable drugs used in total parenteral nutrition (TPN) due to a critical shortage of the products.

Updated House Bill Would Require FDA to Regulate Pharmacies Involved in High-Risk Compounding and Interstate Commerce

Wed, 05 Jun 2013 17:20:00 -0500

United States Representative Edward Markey (D-MA) filed an updated version (PDF) of the Verifying Authority and Legality in Drug (VALID) Compounding Act of 2013 on May, 23, 2013.

Sandoz Recalls Two Lots of Methotrexate Sodium, USP Due to Particulate Matter

Wed, 05 Jun 2013 17:15:00 -0500

Sandoz US is voluntarily recalling two lots of methotrexate sodium, USP, 25 mg/mL, 40 mL vial injectable product because of particulate matter found during a routine test of samples.

Fresenius Kabi USA Recalls Magnesium Sulfate Due to Possible Glass Particles

Wed, 05 Jun 2013 17:10:00 -0500

Fresenius Kabi USA, LLC, is voluntarily recalling one lot of magnesium sulfate injection, USP because of possible glass particles in the vials, according to an FDA alert.

ASOP Shares Information on Global Initiatives for Internet Pharmacy Safety With International Stakeholders in Asia

Wed, 05 Jun 2013 17:05:00 -0500

The Alliance for Safe Online Pharmacies (ASOP) presented information on illegal online drug sellers and its efforts to protect patients from the counterfeit and substandard drugs often distributed by such entities.

Pharmacy Compounding of Sterile Products (Resolution 109-1-13)

Wed, 05 Jun 2013 12:40:00 -0500

Resolution No: 109-1-13 Title: Pharmacy Compounding of Sterile Products Action: Pass Whereas, the patient need for compounded medications has increased and pharmacists compounding safe and effective medications of the required quality for their patients is necessary; and

Prescription Medication Distribution – The Five Percent Rule for Resale (Resolution 109-2-13)

Wed, 05 Jun 2013 12:30:00 -0500

Resolution No:109-2-13 Title: Prescription Medication Distribution – The Five Percent Rule for Resale Action: PASS Whereas, state and federal safeguards, statutes, and regulations for the United States distribution system for prescription drugs secure against adulterated, misbranded, and counterfeit drugs;

Review and Revise the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy Regarding Pharmacy Benefit Managers (Resolution 109-3-13)

Wed, 05 Jun 2013 12:25:00 -0500

Resolution No:109-3-13 Title: Review and Revise the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy Regarding Pharmacy Benefit Managers Action: PASS Whereas, the member boards of the National Association of Boards of Pharmacy

Alternate Patient Medication Information Delivery (Resolution 109-4-13)

Wed, 05 Jun 2013 12:20:00 -0500

Resolution No:109-4-13 Title: Alternate Patient Medication Information Delivery Action: PASS Whereas, it has been observed that the provision of patient information using paper leaflets or attachments to prescription containers and bags may not be read by patients and is often discarded in trash receptacles upon leaving the pharmacy; and

Definition of Pharmacy Compounding (Resolution 109-5-13)

Wed, 05 Jun 2013 12:15:00 -0500

Resolution No:109-5-13 Title: Definition of Pharmacy Compounding Action: PASS Whereas, pharmacy compounding is regulated by the state boards of pharmacy as a part of the practice of pharmacy; and

Compounding and Reconstituting Drugs for Infusion in Establishments Other than Pharmacies (Resolution 109-6-13)

Wed, 05 Jun 2013 12:10:00 -0500

Resolution No:109-6-13 Title: Compounding and Reconstituting Drugs for Infusion in Establishments Other than Pharmacies Action: PASS Whereas, recent tragic events involving contaminated, adulterated, or misbranded products that were compounded and

Performance Metrics and Quotas in the Practice of Pharmacy (Resolution 109-7-13)

Wed, 05 Jun 2013 12:05:00 -0500

Resolution No:109-7-13 Title: Performance Metrics and Quotas in the Practice of Pharmacy Action: PASS Whereas, a survey conducted by the Institute for Safe Medication Practices (ISMP) of 673 pharmacists revealed that 83% believed that distractions due to performance metrics or measured wait times contributed to dispensing errors

Recognition Resolution (Resolution 109-8-13)

Wed, 05 Jun 2013 12:00:00 -0500

Resolution No: 109-8-13 Title: Recognition Resolution Action: PASS Whereas, the individuals listed here have made significant contributions to the National Association of Boards of Pharmacy (NABP), the protection of the public health, and the practice of pharmacy:

NABP Testifies at US House Subcommittee Hearing Regarding Support for Federal Legislation to Distinguish Between Compounding and Manufacturing

Wed, 29 May 2013 18:15:00 -0500

NABP expressed its support for federal legislation that would distinguish between compounding and manufacturing, in testimony presented at a United States House subcommittee hearing on May 23, 2013.

Illinois Legislature Passes Medical Marijuana Bill

Wed, 29 May 2013 18:10:00 -0500

Illinois would establish a four-year medical marijuana pilot program under a bill passed by the state’s Legislature and under review by Illinois Governor Pat Quinn.

Bill To Expand Pharmacists’ Authority to Vaccinate Under Consideration in Pennsylvania Legislature

Wed, 29 May 2013 18:05:00 -0500

Pharmacists in Pennsylvania would be granted authority to vaccinate patients above the age of seven with a parent’s consent under two bills being considered by the Pennsylvania General Assembly.

Three Additional Synthetic Cannabinoids Classified as Schedule I Drugs

Wed, 29 May 2013 18:00:00 -0500

DEA has issued a final order temporarily placing three synthetic cannabinoids into Schedule I of the Controlled Substances Act (CSA).

NABP Expresses Support of Federal Legislation That Distinguishes Compounding From Manufacturing and Clarifies Regulatory Oversight

Thu, 23 May 2013 19:00:00 -0500

National Association of Boards of Pharmacy ^® (NABP^®) has expressed its support for the Pharmaceutical Compounding Quality and Accountability Act.